Who are Picosulfate sodium's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Halflytely, Senna alone, Sodium picosulfate + magnesium citrate, polyethylene glycol, senna, Natrium picosulfate / Magnesium citrate, Sodium Picosulfate/Magnesium Citrate Laxative.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/picosulfate-sodium.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Picosulfate sodium — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Picosulfate sodium (Picosulfate sodium) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Stimulant laxative. Area: Gastroenterology.

marketed Stimulant laxative Myenteric plexus / colonic smooth muscle Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Picosulfate sodium (Picosulfate sodium) — St. Joseph's Healthcare Hamilton. Picosulfate sodium is a stimulant laxative that acts on the colon to promote bowel movements by increasing intestinal motility and fluid secretion.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Picosulfate sodium TARGET	Picosulfate sodium	St. Joseph's Healthcare Hamilton	marketed	Stimulant laxative	Myenteric plexus / colonic smooth muscle
Halflytely	BISACODYL	Braintree	marketed	Stimulant Laxative [EPC]	Kappa-type opioid receptor	2004-01-01
Senna alone	Senna alone	Camlıca Erdem Hospital	marketed	Stimulant laxative	Colonic smooth muscle and intestinal epithelium
Sodium picosulfate + magnesium citrate	Sodium picosulfate + magnesium citrate	Parc de Salut Mar	marketed	Stimulant laxative + osmotic laxative combination
polyethylene glycol, senna	polyethylene glycol, senna	Children's Hospital of Philadelphia	marketed	Osmotic and stimulant laxative combination
Natrium picosulfate / Magnesium citrate	Natrium picosulfate / Magnesium citrate	Tomas Bata Hospital, Czech Republic	marketed	Stimulant laxative / osmotic laxative combination
Sodium Picosulfate/Magnesium Citrate Laxative	Sodium Picosulfate/Magnesium Citrate Laxative	American University of Beirut Medical Center	marketed	Osmotic and stimulant laxative combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Stimulant laxative class)

Camlıca Erdem Hospital · 1 drug in this class
Medtronic - MITG · 1 drug in this class
St. Joseph's Healthcare Hamilton · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Picosulfate sodium — Competitive Intelligence Brief. https://druglandscape.com/ci/picosulfate-sodium. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing